American Pharmacists Association (APhA)
CMSRulemakingCMS-2012-0083

Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, DME Face-to-Face Encounters, Elimination of the Requirement for Termination of Non-Random Prepayment Complex Medical Review and Other Revisions to Part B for CY 2013 (CMS-1590-P)

RIN
Last modified
Apr 21, 2021
Comment window
closed 4957d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Sep 6, 2012 and Sep 6, 2012. 516 other organizations filed here. The comment window closed 4957d ago.

What American Pharmacists Association (APhA) filed (1)

Sep 6, 2012· DC--American Pharmacists Association· CMS-2012-0083-2905

Please see attached comments from the American Pharmacists Association (APhA). In addition, the March 2012 APhA and ASHP white paper on "Improving Care Transitions: Optimizing Medication Reconciliation" is included with the comments.

Abstract

This major proposed rule addresses changes to the physician fee schedule, payments for Part B drugs, and other Medicare Part B payment policies to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. It would also implement provisions of the Affordable Care Act by establishing a faceto- face encounter as a condition of payment for certain durable medical equipment (DME) items. In addition, it would implement statutory changes regarding the termination of non-random prepayment review under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Finally, this proposed rule also includes a discussion regarding the Chiropractic Services Demonstration program.

View on regulations.gov →
Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, DME Face-to-Face Encounters, Elimination of the Requirement for Termination of Non-Random Prepayment Complex Medical Review and Other Revisions to Part B for CY 2013 (CMS-1590-P) (CMS) — American Pharmacists Association (APhA) | OpenPolis